(b).
| Incubation temp. | 1 h 0°C | |||
|
| ||||
| Solution spiked | Vehicle | Low | Med | High |
|
| ||||
| Final MDCO-216 concentration (μg/mL protein): |
0 | 100 | 300 | 1000 |
|
| ||||
| Prebeta-1 HDL net due to plasma* | ||||
| Spiked in plasma 1 | 62 | 75 | 101 | 105 |
| Spiked in plasma 2 | 126 | 126 | 131 | 121 |
| Spiked in plasma 3 | 112 | 144 | 143 | 125 |
| Spiked in plasma average | 100 | 115 | 125 | 117 |
| % of plasma spiked with vehicle** | 115% | 125% | 117% | |
|
| ||||
| Incubation temp. | 1 h 37°C | |||
|
| ||||
| Solution spiked | Vehicle | Low | Med | High |
|
| ||||
| *Final MDCO-216 concentration (μg/mL protein): | 0 | 100 | 300 | 1000 |
|
| ||||
| Prebeta-1 HDL net due to plasma* | ||||
| Spiked in plasma 1 | 5 | 77 | 162 | 379 |
| Spiked in plasma 2 | 12 | 89 | 153 | 375 |
| Spiked in plasma 3 | 23 | 127 | 173 | 401 |
| Spiked in plasma average | 13 | 98 | 163 | 385 |
| % of plasma spiked with vehicle** | 733% | 1220% | 2888% | |
*Value for MDCO-216 spiked in plasma minus value for MDCO-216 spiked in Vehicle (Table 1(a)) in μg/mL. **(value for plasma plus MDCO-216 minus value for MDCO-216 in vehicle)/value for plasma spiked with vehicle.